ClinicalTrials.gg

Immunome, Inc. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 11 studies whose lead sponsor is Immunome, Inc.. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 3, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Immunome with Sino Biopharmaceutical and Bristol-Myers Squibb →

Pipeline: 6 programs

Each counted once: 6 with a study Immunome, Inc. leads registered in the last two years.

  • Phase 1
  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Immunome, Inc.’s own registered studies; Immunome, Inc.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Immunome, Inc.’s studies test, most studies first; none is open now — 2 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

Coming up

1 of Immunome, Inc.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. 1M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 18, 2026.

All 11 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now545%Recruiting 4 · Not yet recruiting 1
  • Under way, not recruiting19%
  • Completed436%
  • Stopped early19%

Phase

  • Phase 110
  • Phase 31
  • Phase 21

Where

  • United States10
  • Spain2
  • France1
  • Netherlands1
  • Korea, Republic of1
  • Australia1

Over the years

  1. 21
  2. 22
  3. 23
  4. 24
  5. 425
  6. 426

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Immunome, Inc..

  • Immunome, Inc.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    11 studies

Studies

Recruiting first, then most recently updated. Showing 11 of 11.